IL6 and acute myeloid leukemia: In addition, Lopes et al. found that IL-6 levels in MSCs correlate with disease progression from MDS to AML, with only slight IL-6 elevations in the MSCs of MDS patients, and higher levels in MSCs from AML patients (112).